Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/13/2025 | $19.00 → $25.00 | Underperform → Neutral | BofA Securities | |
| 3/12/2025 | $175.00 → $170.00 | Sell | Guggenheim | |
| 3/10/2025 | $259.00 → $225.00 | Sell | UBS | |
| 3/7/2025 | $180.00 → $388.00 | Hold → Buy | TD Cowen | |
| 3/7/2025 | $19.00 | Buy | Rosenblatt | |
| 2/28/2025 | $19.00 | Buy | BTIG Research | |
| 2/27/2025 | Buy → Hold | Summit Insights | ||
| 2/12/2025 | $475.00 | Buy | The Benchmark Company |
Tan to join Intel board of directors Intel Corporation (NASDAQ:INTC) today announced that its board of directors has appointed Lip-Bu Tan, an accomplished technology leader with deep semiconductor industry experience, as chief executive officer, effective March 18. He succeeds Interim Co-CEOs David Zinsner and Michelle (MJ) Johnston Holthaus. Tan will also rejoin the Intel board of directors after stepping down from the board in August 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250312399008/en/Lip-Bu Tan was appointed chief executive officer of Intel Corporation in March 2025. He also serves on the company's board of d
ARLINGTON, Va., Feb. 20, 2025 /PRNewswire/ -- Boeing (NYSE:BA) today announced Jeff Shockey as the company's new executive vice president of Government Operations, Global Public Policy & Corporate Strategy, effective Feb. 24. Shockey will lead Boeing's global public policy efforts, including U.S. federal, state and local government operations and sustainability, as well as the company's global philanthropic organization Boeing Global Engagement. Additionally, Shockey will ensure a cohesive corporate strategy to communicate Boeing's business interests and drive engagement with public and private stakeholders. He will report to Boeing President and CEO Kelly Ortberg and serve on the company's
TORONTO, Feb. 6, 2025 /CNW/ - Today, Intel Corporation announced the appointment of Asma Aziz to the position of General Manager for Intel Canada. As a tech industry veteran, Asma brings a wealth of international experience fulfilling various senior marketing and sales positions. With a five-country career spanning across Asia and Americas at Intel, Asma brings a proven track record of driving transformative business growth strategies, fostering high-performance motivated teams, forging impactful partnerships, and delivering results. Prior to her appointment as General Manager for Intel Canada, Asma was leading Marketing for the America's Territories and served as the Interim Regional Chief
New York, New York, March 03, 2025 (GLOBE NEWSWIRE) -- YieldBOOST is an innovative strategy that aims to combine high income potential by selling options on leveraged ETFs which generally command a higher premium than options on stocks, while focusing on NAV preservation by writing options which have a lower chance of being exercised ("out of the money" options). GraniteShares believes that this holistic approach is an improvement over existing option income strategies mainly known as "covered call" strategies. The main problem with covered call strategies is that they prioritize income or yield over total return. With a covered call, the options seller typically sells "at the money" whic
Product to separate the equity and dividend components of a stock and pass-through voting rights Permuto Capital LLC (Permuto), a joint venture between 3V Capital Partners SE LLC (3V Capital Partners) and Chia Network Inc. (Chia), today announced that two additional voting trust investment vehicles (each, a Trust) formed by Permuto have filed registration statements with the Securities and Exchange Commission (SEC) relating to proposed public offerings of a new type of equity product. Permuto will act as the trust administrator of the Trusts. Additionally, Permuto announced submission of a first amended registration statement for a MSFT Trust filed on January 15, 2025. The new products
Transitioned lead commercial responsibility of Nuvaxovid™ COVID-19 vaccine to Sanofi beginning with the 2025-2026 season Achieved total revenue of $88 million in the fourth quarter of 2024 and $682 million for the full year 2024 Achieved $50 million milestone under Sanofi agreement associated with the pediatric clinical trial database lock for the first cohortCompleted $200 million sale of Czech Republic manufacturing facility to Novo Nordisk; reduces annual costs by approximately $80 millionAdvanced pipeline programs, based on proven and innovative technology platformEnded full year 2024 with over $1 billion in Cash and accounts receivablesProvides 2025 financial guidance and revenue framew
4 - INTEL CORP (0000050863) (Issuer)
4 - INTEL CORP (0000050863) (Issuer)
4 - INTEL CORP (0000050863) (Issuer)
SC 13G/A - MARA Holdings, Inc. (0001507605) (Subject)
SC 13G/A - NOVAVAX INC (0001000694) (Subject)
SC 13G/A - MARA Holdings, Inc. (0001507605) (Subject)
BofA Securities upgraded Intel from Underperform to Neutral and set a new price target of $25.00 from $19.00 previously
Guggenheim reiterated coverage of Tesla with a rating of Sell and set a new price target of $170.00 from $175.00 previously
UBS reiterated coverage of Tesla with a rating of Sell and set a new price target of $225.00 from $259.00 previously
4 - NOVAVAX INC (0001000694) (Issuer)
3 - NOVAVAX INC (0001000694) (Issuer)
4 - Tesla, Inc. (0001318605) (Issuer)
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea
For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons
SANTA CLARA, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- NVIDIA today announced ahead of the Game Developers Conference (GDC) groundbreaking enhancements to NVIDIA RTX™ neural rendering technologies. NVIDIA has partnered with Microsoft to bring neural shading support to the Microsoft DirectX preview in April, giving developers access to AI Tensor Cores in NVIDIA GeForce RTX™ GPUs to accelerate neural networks from within a game's graphics pipeline. Neural shading represents a revolution in graphics programming, combining AI with traditional rendering to dramatically boost frame rates, enhance image quality and reduce system resource usage. "Microsoft is adding cooperative vector support
Tan to join Intel board of directors Intel Corporation (NASDAQ:INTC) today announced that its board of directors has appointed Lip-Bu Tan, an accomplished technology leader with deep semiconductor industry experience, as chief executive officer, effective March 18. He succeeds Interim Co-CEOs David Zinsner and Michelle (MJ) Johnston Holthaus. Tan will also rejoin the Intel board of directors after stepping down from the board in August 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250312399008/en/Lip-Bu Tan was appointed chief executive officer of Intel Corporation in March 2025. He also serves on the company's board of d
James Young, PhD retires as Chair of the Board, Margaret McGlynn, RPh, appointedJohn Shiver, PhD appointed to board of directorsGAITHERSBURG, Md., March 11, 2025 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced that James Young, PhD, is retiring as Chair of the Board and Margaret McGlynn, RPh, has been appointed as his successor. The Company also appointed John Shiver, PhD, to its board as an independent director. Dr. Young made the decision to resign from the board effective March 10, 2025. He has served on Novavax's board since 2010 and as Chair since 2011. During
8-K - NOVAVAX INC (0001000694) (Filer)
8-K - NOVAVAX INC (0001000694) (Filer)
8-K - MARA Holdings, Inc. (0001507605) (Filer)